Polysaccharide from Smilax glabra Roxb Mitigates Intestinal Mucosal Damage by Therapeutically Restoring the Interactions between Gut Microbiota and Innate Immune Functions
Nutrients · 22.09.2023 · 15 (19) · 4102
DOI: 10.3390/nu15194102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 22.09.2023. Verfasst von Muhammad Abaidullah und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Henan Agricultural University, Zhengzhou 450002, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Smilax, Colitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Modern Agroindustry Technology Research System of China (CARS-34) and Science and Technology Innovation Team of Henan Province High Quality Forage and Animal H….
Abstract (Originalsprache)
Smilax glabra Roxb (S. glabra) is a conventional Chinese medicine that is mainly used for the reliability of inflammation. However, bioactive polysaccharides from S. glabra (SGPs) have not been thoroughly investigated. Here, we demonstrate for the first time that SGPs preserve the integrity of the gut epithelial layer and protect against intestinal mucosal injury induced by dextran sulfate sodium. Mechanistically, SGPs mitigated colonic mucosal injury by restoring the association between the gut flora and innate immune functions. In particular, SGPs increased the number of goblet cells, reduced the proportion of apoptotic cells, improved the differentiation of gut tight junction proteins, and enhanced mucin production in the gut epithelial layer. Moreover, SGPs endorsed the propagation of probiotic bacteria, including Lachnospiraceae bacterium, which strongly correlated with decreased pro-inflammatory cytokines via the blocking of the TLR-4 NF-κB and MyD88 pathways. Overall, our study establishes a novel use of SGPs for the treatment of inflammatory bowel disease (IBD)-associated mucosal injury and provides a basis for understanding the therapeutic effects of natural polysaccharides from the perspective of symbiotic associations between host innate immune mechanisms and the gut microbiome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Henan Agricultural University, Zhengzhou 450002, China.
- Henan Key Laboratory of Innovation and Utilization of Grassland Resources, Zhengzhou 450002, China.
- Henan Forage Engineering Technology Research Center, Zhengzhou 450002, China.
ORCID-Profile: Shaokai La, Sen Ma
Förderung
- Modern Agroindustry Technology Research System of China (CARS-34) and Science and Technology Innovation Team of Henan Province High Quality Forage and Animal H…
Zitieren
APA
Abaidullah, M., La, S., Liu, M., Liu, B., Cui, Y., Wang, Z., Sun, H., Ma, S., & Shi, Y. (2023). Polysaccharide from Smilax glabra Roxb Mitigates Intestinal Mucosal Damage by Therapeutically Restoring the Interactions between Gut Microbiota and Innate Immune Functions. Nutrients, 15(19), 4102. https://doi.org/10.3390/nu15194102
Vancouver
Abaidullah M, La S, Liu M, Liu B, Cui Y, Wang Z, et al. Polysaccharide from Smilax glabra Roxb Mitigates Intestinal Mucosal Damage by Therapeutically Restoring the Interactions between Gut Microbiota and Innate Immune Functions. Nutrients. 2023;15(19):4102. doi:10.3390/nu15194102
BibTeX
@article{Abaidullah2023,
author = {Abaidullah, Muhammad and La, Shaokai and Liu, Mengqi and Liu, Boshuai and Cui, Yalei and Wang, Zhichang and Sun, Hao and Ma, Sen and Shi, Yinghua},
title = {Polysaccharide from Smilax glabra Roxb Mitigates Intestinal Mucosal Damage by Therapeutically Restoring the Interactions between Gut Microbiota and Innate Immune Functions},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {19},
pages = {4102},
doi = {10.3390/nu15194102}
}
EUVIMED